2022
DOI: 10.1155/2022/6015877
|View full text |Cite
|
Sign up to set email alerts
|

Albumin Paclitaxel Compared with 5-Penfluorouracil, Lobaplatin, and Albumin Paclitaxel Combined with 5-Penfluorouracil in the Treatment of Human Gastric Cancer Cell AGS Line Autophagy and Apoptosis

Abstract: Background. Gastric cancer is one of the most common malignant tumors in the world. Albumin paclitaxel (Nab-PTX) is a novel microtubule inhibitor with albumin as the carrier. Several clinical trials are underway in gastric cancer, but the autophagy mechanism of Nab-PTX on gastric cancer is still unclear. The autophagy and apoptosis effects of Nab-PTX compared with 5-pentafluorouracil (5-Fu) and lobaplatin (LBP) in gastric cancer are also unclear. Objective. This article will compare the effects of Nab-PTX, 5-F… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 51 publications
0
1
0
Order By: Relevance
“…Paclitaxel chemotherapy, a commonly used treatment for advanced gastric cancer, induces cell apoptosis and cycle arrest by inhibiting the reorganization of the normal microtubule network through binding to the microtubule protein β subunit [10,11]. However, the effectiveness of chemotherapy is limited due to acquired and primary drug resistance caused by factors like tumor cell genetic instability and expression heterogeneity [12]. The CHI3L1 gene was identified by Johansen et al in 1992 in the MG63 cell line of human osteosarcoma [13].…”
Section: Discussionmentioning
confidence: 99%
“…Paclitaxel chemotherapy, a commonly used treatment for advanced gastric cancer, induces cell apoptosis and cycle arrest by inhibiting the reorganization of the normal microtubule network through binding to the microtubule protein β subunit [10,11]. However, the effectiveness of chemotherapy is limited due to acquired and primary drug resistance caused by factors like tumor cell genetic instability and expression heterogeneity [12]. The CHI3L1 gene was identified by Johansen et al in 1992 in the MG63 cell line of human osteosarcoma [13].…”
Section: Discussionmentioning
confidence: 99%